ListarMIC - Artículos por tema "SARS-CoV-2"
Mostrando ítems 1-6 de 6
-
A pandemic within other pandemics. When a multiple infection of a host occurs: SARS-CoV-2, HIV and mycobacterium tuberculosis
(2021-05-17)By the middle of 2021, we are still immersed in the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The concurrence of this new pandemic in regions ... -
Detección de variantes del SARS-CoV-2 en aguas residuales de hospitales en Perú, 2022.
(Revista Peruana de Medicina Experimental y Salud Pública, 2024-05-14)Objetivo. Identificar la presencia del virus SARS-CoV-2 en aguas residuales de hospitales en Perú. Materiales y métodos. Se recolectaron muestras de agua en los efluentes de nueve hospitales del Perú durante marzo y ... -
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
(Springer Nature, 2021)COVID-19 is a disease with unique characteristics that include lung thrombosis1, frequent diarrhoea2, abnormal activation of the inflammatory response3 and rapid deterioration of lung function consistent with alveolar ... -
Interferon-stimulated genes and their antiviral activity against SARS-CoV-2.
(American Society of Microbiology, 2024)The coronavirus disease 2019 (COVID-19) pandemic remains an international health problem caused by the recent emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of May 2024, SARS-CoV-2 has ... -
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
(2020)Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10-15 d after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-2 in the human population, it is not known how ... -
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
(Elsevier, 2021)Interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the receptor ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing antibodies, and several neutralizing epitopes ...